Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1

Br J Dermatol. 2024 Jan 23;190(2):e20. doi: 10.1093/bjd/ljad515.NO ABSTRACTPMID:38262593 | DOI:10.1093/bjd/ljad515
Source: The British Journal of Dermatology - Category: Dermatology Source Type: research